Peptides are a group of biologically active substances that are involved in various cellular functions of organisms.Peptides are frequently utilized in functional analysis, research on vaccines, and particularly in the production of pharmaceuticals. More than 80 peptide medications are already available on the market to treat a variety of illnesses, such as diabetes, cancer, osteoporosis, multiple sclerosis, HIV infection, and chronic pain.
Structure | Cat No. | Product Name | CAS No. | Product Description |
---|---|---|---|---|
![]() |
V36279 | H-Arg(Pbf)-2-Chlorotrityl Resin | H-Asn(Trt)-2-Chlorotrityl Resin is a peptide compound. | |
![]() |
V36390 | H-Arg-Arg-Glu-Glu-Glu-Thr-Glu-Glu-Glu-OH | H-Arg-Arg-Glu-Glu-Glu-Thr-Glu-Glu-Glu-OH is a peptide compound. | |
![]() |
V36910 | H-Arg-Arg-Leu-Ile-Glu-Asp-Asn-Glu-Tyr-Thr-Ala-Arg-Gly-OH | 81493-98-3 | pp60v-src Autophosphorylation site is a synthetic peptide. |
![]() |
V36535 | H-Arg-Asn-Ile-Ala-Glu-Ile-Ile-Lys-Asp-Ile-OH | 120180-27-0 | H-Arg-Asn-Ile-Ala-Glu-Ile-Ile-Lys-Asp-Ile-OH is a peptide compound. |
![]() |
V35298 | H-Arg-Gln-OH | 2483-17-2 | Arginyl-Glutamine is a dipeptide that reduces VEGF levels and inhibits retinal neovascularization in a mouse model of oxygen-induced retinopathy. |
![]() |
V35299 | H-Arg-Gly-NH2·sulfate | 34367-76-5 | H-Arg-Gly-NH2·sulfate is a peptide compound. |
![]() |
V35300 | H-Arg-Gly-OH·HCl | 105241-88-1 | H-Arg-Gly-OH·HCl is a peptide compound. |
![]() |
V36911 | H-Arg-Gly-Tyr-Ala-Leu-Gly-OH | 59587-24-5 | H-Arg-Gly-Tyr-Ala-Leu-Gly-OH is a competitive, CAMP-dependent protein kinase inhibitor. |
![]() |
V35301 | H-Arg-His-NH2 | 244765-93-3 | Arg-His-NH2 is a bioactive peptide discovered by peptide screening. |
![]() |
V35302 | H-Arg-Leu-OH | 1188-24-5 | Arg-Leu is a bioactive peptide discovered by peptide screening. |
![]() |
V36912 | H-Arg-Lys-Arg-Ser-Arg-Ala-Glu-OH | 81187-14-6 | PKG Substrate is a selective substrate for cGMP-dependent protein kinase (PKG). |
![]() |
V35303 | H-Arg-Lys-Arg-Thr-Leu-Arg-Arg-Leu-OH | 152246-44-1 | H-Arg-Lys-Arg-Thr-Leu-Arg-Arg-Leu-OH is a peptide compound. |
![]() |
V36913 | H-Arg-Lys-Ile-Ser-Ala-Ser-Glu-Phe-Asp-Arg-Pro-Leu-Arg-OH | H-Arg-Lys-Ile-Ser-Ala-Ser-Glu-Phe-Asp-Arg-Pro-Leu-Arg-OH is a peptide compound. | |
![]() |
V35304 | H-Arg-Lys-OH | 40968-46-5 | H-Arg-Lys-OH is a dipeptide formed from L-arginine and L-lysine residues. |
![]() |
V35305 | H-Arg-Met-NH2 | 121185-77-1 | H-Arg-Met-NH2 is a peptide compound. |
![]() |
V36117 | H-Arg-PNA.2HCl | 40127-11-5 | H-Arg-PNA.2HCl is a peptide compound. |
![]() |
V35306 | H-Arg-Pro-pNA | 112898-06-3 | H-Arg-Pro-pNA is a peptide compound. |
![]() |
V35307 | H-Arg-Ser-Arg-His-Phe-OH | 105931-70-2 | H-Arg-Ser-Arg-His-Phe-OH is a peptide compound. |
![]() |
V35308 | H-ARG-SER-ARG-OH ACETATE SALT | 115035-42-2 | H-Arg-Ser-Arg-OH is a short peptide. |
![]() |
V35309 | H-Arg-Trp-NH2·2 HCl | 281659-95-8 | H-Arg-Trp-NH2·2 HCl is a peptide compound. |